drugset / Trial / NCT00259805

A Pilot Study of the Use of Rituximab in the Treatment of Chronic Focal Encephalitis

NCT00259805 ↗

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the safety, tolerability and effectiveness of rituximab in the treatment of chronic focal encephalitis.

Timeline

Start
2005-01
Primary completion
2008-12
Completion
2008-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Rituximab Monoclonal antibody 375 mg/m2 Intravenous